Briacell Therapeutics Corp. Common Shares
Symbol: BCTX (NASDAQ)
10.93
▼ (-0.68%) -0.075
Company Description:
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
Key Stats
- Today's Open: $10.925
- Today's High: $10.925
- Today's Low: $10.925
- Today's Volume: 7
- Yesterday Close: $11
- Yesterday High: $11.01
- Yesterday Low: $10.7601
- Yesterday Volume: 25.32K
- Last Min Volume: 7
- Last Min High: $10.925
- Last Min Low: $10.925
- Last Min VWAP: $10.925
Company Profile
- Name: Briacell Therapeutics Corp. Common Shares
- Website: https://www.briacell.com
- Listed Date: 2023-09-05
- Location: WEST VANCOUVER, A1
- Market Status: Active
- CIK Number: 0001610820
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $19.31M
- Round Lot: 100
- Outstanding Shares: 1.76M
- Asset Type: CS
RECENT FILINGS FOR BCTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-26 | 8-K | View |
| 2025-08-01 | S-8 | View |
| 2025-07-28 | SCHEDULE 13G | View |
| 2025-07-22 | SCHEDULE 13G | View |
| 2025-07-21 | SCHEDULE 13G/A | View |
| 2025-07-16 | 8-K | View |
| 2025-07-16 | 424B4 | View |
| 2025-07-15 | EFFECT | View |
| 2025-07-15 | CORRESP | View |
| 2025-07-15 | CORRESP | View |
| 2025-07-14 | CORRESP | View |
| 2025-07-14 | CORRESP | View |
| 2025-07-11 | CORRESP | View |
| 2025-07-11 | CORRESP | View |
| 2025-07-11 | FWP | View |
| 2025-07-10 | S-1/A | View |
| 2025-07-09 | S-1/A | View |
| 2025-07-08 | FWP | View |
| 2025-07-08 | CORRESP | View |
| 2025-07-08 | CORRESP | View |
Latest News on BCTX